Study Group: Diagnostic Radiologists :Nuclear Radiology
Council Members in this Study Group: 139
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Volker HoffmannPartner/Owner
Diagnostic Imaging Center
Volker Hoffmann, MD, is a Diagnostic and Interventional Radiologist and one of the three owners of Diagnostic Imaging Center, a large private imaging center. <br/><br/>He was a Product Manager and Medical Consultant at Strategic Marketing of the Global...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
NSF (Nephrogenic Systemic Fibrosis) - Gadoxetic Acid (Primovist)
October 9, 2007
Analysis by: Volker Hoffmann, Partner/Owner,Study Finds NSF More Common Than Previously Reported | www.dimag.com
Nephrogenic systemic fibrosis is becoming a severe problem for radiologist and industry as it may prevent physicians from using gadolinium containing contrast agents fearing that they induce nephrogenic systemic fibrosis even in patients without known kidney disease. A stable contrast agent with almost no release of gadolinium may be a solution: gadoxetic acid, sold in Europe and Asia as Primovist.
-
IMDS - CTML - Value without contrast agents?
May 14, 2007
Analysis by: Volker Hoffmann, Partner/Owner,Imaging Diagnostic Systems Breast Scanner Performance Upgrade Program Nearing Completion | www.medicalnewstoday.com
The recent upgrade of the Computed Tomography Laser Mammography (CTLM(R)) system will only added minor details. The question whether this system without any contrast agent is of any value has not been answered so far.
-
Impropved pancreatic duct imaging in MR - small market for Secretin
May 14, 2007
Analysis by: Volker Hoffmann, Partner/Owner,Repligen Reports Positive Phase 2 Clinical Trial Results Of Secretin For MRI Imaging Of The Pancreas | www.medicalnewstoday.com
Pancreatic duct imaging is currently done with a heavily weighted T2 sequence that requires water in the duct for imaging. Increased production of pancreatic juice may make imaging easier. This is however a very small niche market which by itself will not allow survival of RG1068.
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
- Government/Military Hospital or Clinic
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Physician - Director
- Physician - Division Head
- Professor
- Director
Related Study Groups
| Study Group Name | No. Members |
|---|---|
| Radiologists (US) | 708 |
| Diagnostic Radiologists (US) | 438 |
| Diagnostic Radiologists (EU) | 138 |
| Radiologists (EU) | 249 |
| Radiology Department Heads (US) | 153 |
| General Cardiologists (US) | 1327 |
| Physicians (Germany) | 1172 |
| Oncologists (EU) | 761 |